“…Worldwide, there have been few reports on the impact of the COVID-19 pandemic on cancer screening beyond 2021. In the United States and Brazil, breast, cervical, and prostate cancer screening rates declined significantly in 2020 and did not recover to 2019 levels even in 2021 ( Oakes et al, 2023 , Antonini et al, 2023 ). Another US report found that colorectal cancer screening rates in 2021 exceeded those in 2019 ( Star et al, 2023 ).…”